持续关注新冠疫情：中国临床指南的变化。
Continuous focus on COVID-19 epidemic: Changes in China's clinical guidance.
机构信息
Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
出版信息
Int J Clin Pract. 2021 Mar;75(3):e13869. doi: 10.1111/ijcp.13869. Epub 2020 Dec 16.
BACKGROUNDS
The epidemic of coronavirus disease 2019 (COVID-19) is spreading across the world. As the first country who suffered from the outbreak, China has been taking strict and effective measures to contain the epidemic and treat the disease under the instruction of updating guidance.
AIMS
To compare the changes and updates in China's clinical guidance for COVID-19.
METHODS
We explored China's experience in dealing with the epidemic by longitudinal comparison of China's clinical guidance for COVID-19.
RESULTS
As of March 4, there are 7 editions of the guidance. With the increasing understanding of COVID-19, changes have been made in aetiology, epidemiology, pathology, clinical features, diagnostic criteria, clinical classification, and treatment.
CONCLUSIONS
We have made a summary of the changes and updates in China's clinical guidance for COVID-19, which mirrors the deepening understanding of the disease over the course of fighting it, hoping to help clinicians worldwide.
背景
2019 年冠状病毒病（COVID-19）疫情在全球蔓延。作为首个遭受疫情的国家，中国在不断更新的指导意见的指导下，采取了严格有效的措施来控制疫情和治疗疾病。
目的
比较中国 COVID-19 临床指南的变化和更新。
方法
通过对中国 COVID-19 临床指南的纵向比较，探讨中国应对疫情的经验。
结果
截至 3 月 4 日，共发布了 7 版指南。随着对 COVID-19 的认识不断加深，病因、流行病学、病理学、临床特征、诊断标准、临床分类和治疗方法都发生了变化。
结论
我们总结了中国 COVID-19 临床指南的变化和更新，反映了在抗击疫情过程中对疾病认识的不断深化，希望能为全球临床医生提供帮助。
Zotero 插件